Advertisement

Antiepileptika

  • Ulrich Schwabe

Zusammenfassung

Entsprechend den derzeitigen Therapieempfehlungen konzentrieren sich 69% der Antiepileptikaverordnungen auf die drei Standardtherapeutika Carbamazepin, Valproinsäure und Phenytoin.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. for the Gabapentin Diabetic Neuropathy Study Group (1998): Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 280:1831–1836.PubMedCrossRefGoogle Scholar
  2. Ben-Menachem E, Scheepers B, Stodieck S (2003): Epilepsy: from consensus to daily practice. Acta Neurol Scand 108(Suppl 180): 5–15.CrossRefGoogle Scholar
  3. Beydoun A (1997): Monotherapy trials of new antiepileptic drugs. Epilepsia 38(Suppl 9):S21–S31.PubMedCrossRefGoogle Scholar
  4. Beydoun A (1999): Monotherapy trials with gabapentin for partial epilepsy. Epilepsia 40(Suppl 6): S13–S16.PubMedCrossRefGoogle Scholar
  5. Charatan F (2002): Doctor sues company over unethical marketing. Brit Med J 324: 1234.PubMedCrossRefGoogle Scholar
  6. Dooley M, Plosker GL (2000): Levetiracetam. A review of its adjunctive use in the management of partial onset seizures. Drugs 60: 871–893.PubMedCrossRefGoogle Scholar
  7. Feely M (1999): Drug treatment of epilepsy. Brit Med J 318:106–109.PubMedCrossRefGoogle Scholar
  8. Goa KL, Ross SR, Chrisp P (1993): Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 46:152–176.PubMedCrossRefGoogle Scholar
  9. Groß-Selbeck G (1995): Treatment of „benign“ partial epilepsies of childhood, including atypical forms. Neuropediatrics 26:45–50.PubMedCrossRefGoogle Scholar
  10. Heaney DC, Shorvon SD, Sander JW (1998): An economic appraisal of carbamazepine, lamotrigine, phenytoin and valproate as initial treatment in adults with newly diagnosed epilepsy. Epilepsia 39(Suppl 3): S19–S25.PubMedCrossRefGoogle Scholar
  11. Hufnagel A, Noachtar S (1998): Epilepsien und ihre medikamentöse Behandlung. In: Brandt T, Dichgans J, Diener HC (Hrsg): Therapie und Verlauf neurologischer Erkrankungen. 3. Aufl., Kohlhammer, Stuttgart, Berlin, Köln, S. 179–203.Google Scholar
  12. Jette NJ, Marson AG, Kadir ZA, Hutton JL (2000): Topiramate for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2: CD001417.Google Scholar
  13. McKee PJ, Blacklaw J, Forrest G, Gillham RA, Walker SM, Connelly D, Brodie MJ (1994): A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. Br J Clin Pharmacol 37: 27–32.PubMedCrossRefGoogle Scholar
  14. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA (1999): Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159:1931–1937.PubMedCrossRefGoogle Scholar
  15. Stefan H, Halász P, Gil-Nagel A, Shorvon S, Bauer G, Ben-Menachem E et al. (2001): Recent advances in the diagnosis and treatment of epilepsy. Eur J Neurol 8: 519–539.PubMedCrossRefGoogle Scholar
  16. Visintini D, Calzetti S, Mancia D (1981): Il barbexaclone nel trattamento delle epilessie. Riv Patol Nerv Ment 102:29–37.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • Ulrich Schwabe
    • 1
  1. 1.Pharmakologisches Institut der Universität HeidelbergHeidelberg

Personalised recommendations